Li Yun-Ge, Wang Ju-Xian, Zhang Guo-Ning, Zhu Mei, You Xue-Fu, Hu Xin-Xin, Zhang Fan, Wang Yu-Cheng
School of Pharmacy, Jinzhou Medical University, Jinzhou, 121001, P. R. China.
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, P. R. China.
Chem Biodivers. 2019 Feb;16(2):e1800560. doi: 10.1002/cbdv.201800560. Epub 2019 Jan 28.
A series of novel thioether or sulfoxide-type pleuromutilin derivatives containing heteroaromatic substituents at the end of C14 side chain were designed and synthesized. All of the derivatives were evaluated for their in vitro antibacterial activity. Some of them showed good to excellent antibacterial activity comparable to retapamulin and azamulin in most of the tested Gram-positive pathogens. In this work, a five-membered heterocyclic moiety, a pyrimidine-heterocyclic moiety, or a benzoheterocyclic moiety was introduced in the C14 side chain to increase the structural diversity of the pleuromutilin derivatives. The antibacterial results reveal that the thioether-containing pleuromutilin derivatives exert a more potency activity than the sulfoxide-type derivatives against Gram-positive pathogens. The structure-activity relationship summarized in this work may provide with some interesting clues as to which functionalities are beneficial for high antimicrobial activity of the pleuromutilin derivatives.
设计并合成了一系列在C14侧链末端含有杂芳族取代基的新型硫醚或亚砜型截短侧耳素衍生物。对所有衍生物进行了体外抗菌活性评估。其中一些在大多数测试的革兰氏阳性病原体中表现出与瑞他帕林和阿扎霉素相当的良好至优异的抗菌活性。在这项工作中,在C14侧链中引入了五元杂环部分、嘧啶杂环部分或苯并杂环部分,以增加截短侧耳素衍生物的结构多样性。抗菌结果表明,含硫醚的截短侧耳素衍生物对革兰氏阳性病原体的活性比亚砜型衍生物更强。这项工作总结的构效关系可能为哪些官能团有利于截短侧耳素衍生物的高抗菌活性提供一些有趣的线索。